Relevant state departments have issued a series of laws and regulations and guiding principles to promote the healthy development of stem cells.

As a new treatment, cell therapy has shown good results in the treatment of many diseases, especially cancer and genetic diseases.

Cell and gene therapy (CGT), as the representative of innovative medical technology, is gradually moving from laboratory to clinical application, bringing new hope to patients.

Global biological cell technology and its related industries are experiencing rapid development, which is promoting the transformation of modern medicine from traditional treatment to cell therapy.

According to the latest research and clinical data, intravenous infusion of mesenchymal stem cells is safe with no serious side effects or adverse reactions.

As two hot spots in the field of cell therapy, stem cells and exosomes have their own unique characteristics and potential, but there is also a close relationship between them.

This paper summarizes the industry guidelines related to cell and gene therapy issued by the Food and Drug Administration (FDA).

Stem cell technology is expected to revolutionize the healthcare industry in an unprecedented way, especially in the fight against chronic diseases, in the next five to 10 years.